tbuckley/cabot-search huggingface dataset:
Metagenomic sequencing with spiked-in internal control to monitor cellularity and diagnosis of pneumonia
Authors: Hua Zhou, Chuan Ouyang, Xu Han, Lisha Shen, Jian Ye, Zhixian Fang, Wenyu Chen, Aifeng Chen, Qiang Ma, Maohong Hua, Junfei Zhu, Xiaomai Wu, Xuemei Lin, Yuexiang Shui, Changsheng Zhou, Kai Fang, Junwei Du, Zhihui Huang, Gang Wang, Qun Lv, Weina Huang, Jun Wang, Xiaoting Hua, Jianying Zhou, Chao Liu, Yunsong Yu
Journal: Journal of Infection (2021)
Is the MSB hypothesis (music as a coevolved system for social bonding) testable in the Popperian sense?
Authors: Jonathan B. Fritz
Journal: Behavioral and Brain Sciences (2021)

Abstract “Music As a Coevolved System for Social Bonding” (MSB) is a brilliant synthesis and appealing hypothesis offering insights into the evolution and social bonding of musicality, but is so broad and sweeping it will be challenging to test, prove or falsify in the Popperian sense (Popper, 1959). After general comments, I focus my critique on underlying neurobiological mechanisms, and offer some suggestions for experimental tests of MSB.
What Are We Waiting for?—Start Screening High-risk Individuals for Anal Cancer Now—Reply
Authors: Justin D. Arnold, Anne K. Monroe, Stephen E. Abbott
Journal: JAMA Dermatology (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Dermatology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Dermatology journal
Abstract 16332: ABC Transporter Genes and Risk of Type 2 Diabetes - A Study of 40,000 Individuals from the General Population
Authors: Jesper Schou, Anne Tybjaerg-Hansen, Holger Jon Moller, Borge G Nordestgaard, Ruth Frikke-Schmidt
Journal: Circulation (2012)

Objective: Alterations of pancreatic β-cell cholesterol content may contribute to β-cell dysfunction. Two important determinants of intracellular cholesterol content are the ATP-Binding-Cassette tr...
760P Straightforward molecular tests for predicting response and non-response to platinum-based neoadjuvant therapy in high-grade serous ovarian cancer patients
Authors: E.N. Imyanitov, A. Sokolenko, T. Gorodnova, I.V. Bizin, E.S. Kuligina, K. Kotiv, A. Romanko, T. Ermachenkova, A.O. Ivantsov, E. Preobrazhenskaya, T. Sokolova, S. Aleksakhina, R. Broyde, I. Berlev
Journal: Annals of Oncology (2021)
腎虚血/再灌流傷害から保護するフィブリノゲンβ由来のBβ 15-42 ペプチド
Authors: Krishnamoorthy Aparna, Ajay Amrendra Kumar, Hoffmann Dana, Kim Tae-Min, Ramirez Victoria, Campanholle Gabriela, A Bobadilla Norma, S Waikar Sushrut, S Vaidya Vishal
Journal: Blood (2011)
CXCL12 and CCL21 chemokine expression in inflammatory draining lymph nodes promote melanoma metastasis
Authors: Minoru Kitago, Steve R. Martinez, Kazuo Koyanagi, Takuji Mori, Roderick R. Turner, Dave S B Hoon
Journal: Cancer Research (2006)

294  Purpose: One of the most important prognostic factors for patients with early-stage melanoma is the tumor status of the lymph nodes draining the primary tumor. Tumor cell metastasis share many similarities with leukocyte trafficking, whereby both processes can be regulated by chemokines and respective receptors. The chemokine receptors CXCR4 and CCR7 have been reported to be expressed on melanoma cells. We hypothesized that the respective ligands, CXCL12(SDF-1) and CCL21, can facilitate recruitment and establishment of metastasis of melanoma cells from a primary tumor lesion to inflammatory tumor-draining sentinel lymph nodes (SLN). Materials and Methods: A total of 129 SLN from 124 patients were assessed. Quantitative real-time reverse transcriptase-PCR (qRT) assay was used to assess the expression level of CXCL12 and CCL21 in paraffin-embedded SLN with (n=37) and without (n=92) metastasis from melanoma patients. GAPDH gene was used as a control housekeeping gene. All SLN were assessed by immunohistochemistry (IHC) and HE p=0.02) and in HE p=0.04). The mean CCL12:GAPDH mRNA copy level ratio was also significantly higher in micrometastasis positive SLN (ratio, 3.66±0.37) than in macrometastasis positive SLN (ratio, 1.54±0.42; p=0.006) and in HE p
1548P A phase Ia/Ib, dose-escalation/expansion study of the MDM2–p53 antagonist BI 907828 in patients (pts) with advanced/metastatic sarcoma
Authors: M. Gounder, M.R. Patel, N. Yamamoto, T.M. Bauer, S. Laurie, A. Perez-Pitarch, J. Geng, J. Cheng, M. Lahmar, P. Lorusso
Journal: Annals of Oncology (2021)
EU institutions have made major improvements in reporting trial results, report finds
Authors: Barbara Casassus
Journal: BMJ (2021)

Major European research institutions have shown a “dramatic improvement” in their rates of reporting clinical trial results, and most are now actively uploading backlogs of missing results to an EU database, a progress report has found.1

Twenty one of the 26 largest medical research institutions in the EU’s 27 countries are “now clearly working to clear their backlogs,” said the report from Cochrane Austria and the advocacy groups TranspariMED and Health Action International. However, five institutions, all located in Italy and the Netherlands, showed “no clear sign of progress” on this.

New EU guidelines, stating that trial results should be uploaded to its database within 12 months of completion for adult drugs and six months for paediatric drugs, will become national law in every member state from 31 January 2022.

“I am delighted that so many prominent European institutions, each with more than 100 drug studies behind them, are clearing their backlogs,” said Till Bruckner, TranspariMED’s founder and the author of the report.

“They have started at different times and are progressing at different speeds, but altogether they show a massive trend towards greater transparency …
1287P Immune T-cell subpopulations from the peripheral blood of non-small cell lung cancer patients are associated with the efficacy of anti-PD-1 immunotherapy
Authors: J. Rogado, F. Pozo, K. Troulè, J.M. Sánchez-Torres, N. Romero Laorden, R. Mondéjar Solís, O. Donnay Candil, A.I. Ballesteros García, V. Pacheco-Barcia, J. Aspa, F. Al-Shahrour, A. Alfranca, R. Colomer
Journal: Annals of Oncology (2021)
202TiP ASTEFANIA: A phase III study of trastuzumab emtansine (T-DM1) plus atezolizumab or placebo as adjuvant therapy in patients with residual invasive breast cancer after neoadjuvant HER2-targeted therapy and chemotherapy
Authors: P. Schmid, T. Bachelot, G. Bianchini, N. Harbeck, S. Loi, Y.H. Park, A. Prat, L. Gilham, T. Boulet, N. Gochitashvili, E. Monturus, C. Lambertini, B. Nyawira, A. Knott, S.A. Hurvitz
Journal: Annals of Oncology (2021)
Assessing Performance of Machine Learning—Reply
Authors: Rohan Khera, Bobak J. Mortazavi, Harlan M. Krumholz
Journal: JAMA Cardiology (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Cardiology HomeNew OnlineCurrent IssueFor Authors Podcast Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Cardiology journal
1410P Gastric cancer: Data from the AGAMENON-SEOM study
Authors: I. Macias Declara, L. Mihic, A. Calvo, R. Hernandez, N. Castro Unanua, D. Cacho, A. Custodio, J.M. Cano, A. Fernandez Montes, M. Diez, F. López, L. Visa Turmo, R. Vidal Tocino, M.L. Limon, P. Pimentel, M. Mangas Izquierdo, D. Paez, E. Asensio-Martinez, A. Carmona-Bayonas, P. Jimenez-Fonseca
Journal: Annals of Oncology (2021)
CPEB alteration and aberrant transcriptome-polyadenylation lead to a treatable SLC19A3 deficiency in Huntington’s disease
Authors: Sara Picó, Alberto Parras, María Santos-Galindo, Julia Pose-Utrilla, Margarita Castro, Enrique Fraga, Ivó H. Hernández, Ainara Elorza, Héctor Anta, Nan Wang, Laura Martí-Sánchez, Eulàlia Belloc, Paula Garcia-Esparcia, Juan J. Garrido, Isidro Ferrer, Daniel Macías-García, Pablo Mir, Rafael Artuch, Belén Pérez, Félix Hernández, Pilar Navarro, José Luis López-Sendón, Teresa Iglesias, X. William Yang, Raúl Méndez, José J. Lucas
Journal: Science Translational Medicine (2021)

Altered CPEBs and mRNA polyadenylation lead to thiamine deficiency in the brains of patients and mice with Huntington’s disease.
Incidence Rates, Household Infection Risk, and Clinical Characteristics of SARS-CoV-2 Infection Among Children and Adults in Utah and New York City, New York
Authors: Fatimah S. Dawood, Christina A. Porucznik, Vic Veguilla, Joseph B. Stanford, Jazmin Duque, Melissa A. Rolfes, Ashton Dixon, Priyam Thind, Emily Hacker, Maria Julia E. Castro, Zuha Jeddy, Michael Daugherty, Kim Altunkaynak, Danielle Rentz Hunt, Utsav Kattel, Jennifer Meece, Melissa S. Stockwell
Journal: JAMA Pediatrics (2021)

Data about the risk of SARS-CoV-2 infection among children compared with adults are needed to inform COVID-19 risk communication and prevention strategies, including COVID-19 vaccination policies for children.To compare incidence rates and clinical characteristics of SARS-CoV-2 infection among adults and children and estimated household infection risks within a prospective household cohort.Households with at least 1 child aged 0 to 17 years in selected counties in Utah and New York City, New York, were eligible for enrollment. From September 2020 through April 2021, participants self-collected midturbinate nasal swabs for reverse transcription-polymerase chain reaction testing for SARS-CoV-2 and responded to symptom questionnaires each week. Participants also self-collected additional respiratory specimens with onset of COVID-19-like illness. For children unable to self-collect respiratory specimens, an adult caregiver collected the specimens.The primary outcome was incident cases of any SARS-CoV-2 infection, including asymptomatic and symptomatic infections. Additional measures were the asymptomatic fraction of infection calculated by dividing incidence rates of asymptomatic infection by rates of any infection, clinical characteristics of infection, and household infection risks. Primary outcomes were compared by participant age group.A total of 1236 participants in 310 households participated in surveillance, including 176 participants (14%) who were aged 0 to 4 years, 313 (25%) aged 5 to 11 years, 163 (13%) aged 12 to 17 years, and 584 (47%) 18 years or older. Overall incidence rates of SARS-CoV-2 infection were 3.8 (95% CI, 2.4-5.9) and 7.7 (95% CI, 4.1-14.5) per 1000 person-weeks among the Utah and New York City cohorts, respectively. Site-adjusted incidence rates per 1000 person-weeks were similar by age group: 6.3 (95% CI, 3.6-11.0) for children 0 to 4 years, 4.4 (95% CI, 2.5-7.5) for children 5 to 11 years, 6.0 (95% CI, 3.0-11.7) for children 12 to 17 years, and 5.1 (95% CI, 3.3-7.8) for adults (≥18 years). The asymptomatic fractions of infection by age group were 52%, 50%, 45%, and 12% among individuals aged 0 to 4 years, 5 to 11 years, 12 to 17 years, and 18 years or older, respectively. Among 40 households with 1 or more SARS-CoV-2 infections, the mean risk of SARS-CoV-2 infection among all enrolled household members was 52% (range, 11%-100%), with higher risks in New York City compared with Utah (80% [95% CI, 64%-91%] vs 44% [95% CI, 36%-53%]; P < .001).In this study, children had similar incidence rates of SARS-CoV-2 infection compared with adults, but a larger proportion of infections among children were asymptomatic.
Assessing Performance of Machine Learning
Authors: Konrad Pieszko, Piotr J. Slomka
Journal: JAMA Cardiology (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Cardiology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Cardiology journal
1172MO Durvalumab consolidation in patients with stage III non-resecable NSCLC with driver genomic alterations
Authors: M. Riudavets Melia, E. Auclin, M.A. Mosteiro Lamas, N. Dempsey, M. Majem, R. Lobefaro, R. Lopez Castro, J. Bosch Barrera, S. Pilotto, E. Escalera Martín, M. Tagliamento, J. Mosquera Martinez, G. Zalcman, E. Nadal, G. Lopes, D. Signorelli, M.R. Garcia Campelo, B. Besse, D. Planchard, L. Mezquita
Journal: Annals of Oncology (2021)
Female authorship of covid-19 research in manuscripts submitted to 11 biomedical journals: cross sectional study
Authors: Angèle Gayet-Ageron, Khaoula Ben Messaoud, Mark Richards, Sara Schroter
Journal: BMJ (2021)

To describe prominent authorship positions held by women and the overall percentage of women co-authoring manuscripts submitted during the covid-19 pandemic compared with the previous two years.Cross sectional study.Nine specialist and two large general medical journals.Authors of research manuscripts submitted between 1 January 2018 and 31 May 2021.Primary outcome: first author's gender.last and corresponding authors' gender; number (percentage) of women on authorship byline in "pre-pandemic" period (1 January 2018 to 31 December 2019) and in "covid-19" and "non-covid-19" manuscripts during pandemic.A total of 63 259 manuscripts were included. The number of female first, last, and corresponding authors respectively were 1313 (37.1%), 996 (27.9%), and 1119 (31.1%) for covid-19 manuscripts (lowest values in Jan-May 2020: 230 (29.4%), 165 (21.1%), and 185 (22.9%)), compared with 8583 (44.9%), 6118 (31.2%), and 7273 (37.3%) for pandemic non-covid-19 manuscripts and 12 724 (46.0%), 8923 (31.4%), and 10 981 (38.9%) for pre-pandemic manuscripts. The adjusted odds ratio of having a female first author in covid-19 manuscripts was <1.00 in all groups (P<0.001) compared with pre-pandemic (lowest in Jan-May 2020: 0.55, 98.75% confidence interval 0.43 to 0.70). The adjusted odds ratio of having a woman as last or corresponding author was significantly lower for covid-19 manuscripts in all time periods (except for the two most recent periods for last author) compared with pre-pandemic (lowest values in Jan-May 2020: 0.74 (0.57 to 0.97) for last and 0.61 (0.49 to 0.77) for corresponding author). The odds ratios for pandemic non-covid-19 manuscripts were not significantly different compared with pre-pandemic manuscripts. The median percentage of female authors on the byline was lower for covid-19 manuscripts (28.6% in Jan-May 2020) compared with pre-pandemic (36.4%) and non-covid-19 pandemic manuscripts (33.3% in Jan-May 2020). Gender disparities in all prominent authorship positions and the proportion of women authors on the byline narrowed in the most recent period (Feb-May 2021) compared with the early pandemic period (Jan-May 2020) and were very similar to values observed for pre-pandemic manuscripts.Women have been underrepresented as co-authors and in prominent authorship positions in covid-19 research, and this gender disparity needs to be corrected by those involved in academic promotion and awarding of research grants. Women attained some prominent authorship positions equally or more frequently than before the pandemic on non-covid-19 related manuscripts submitted at some time points during the pandemic.
1006P ACE1702, a first-in-class, off-the-shelf, selected natural killer cell [oNK] product using antibody cell conjugation technology [ACC], with pre-clinical and early clinical activity in HER2 &lt; 3+ tumors
Authors: S.A. Piha-Paul, D. Mahalingam, M.F. Mulcahy, A. Kalyan, H-K. Li, E. Wu, M. Kurman, S. Lee, Y-L. Lin, S-W. Tang, C-W. Hsiao, J. Pan, S. Chien
Journal: Annals of Oncology (2021)
1830P Early deaths (ED) upon first-line immunecheckpoint inhibitors (ICI) alone or combined to other non-ICI drugs across solid cancers: A systematic review and meta-analysis
Authors: G. Viscardi, V. Simeon, F. Massari, S. Alfieri, M. Lambertini, M. Imbimbo, V. Mollica, A. Rizzo, F. Comito, G. Lo Russo, C. Proto, A. Prelaj, G. Galli, A. De Toma, A. Tralongo, M. Cinquini, F. Morgillo, M.C.C. Garassino, V. Torri, R. Ferrara
Journal: Annals of Oncology (2021)
1041MO 5-year update on COLUMBUS: A randomized phase III trial of encorafenib (enco) + binimetinib (bini) versus enco or vemurafenib (vem) in patients (pts) with BRAF V600-mutant melanoma
Authors: R. Dummer, K.T. Flaherty, C. Robert, A. Arance, J.W.B. de Groot, C. Garbe, H.J. Gogas, R. Gutzmer, I. Krajsová, G. Liszkay, C. Loquai, M. Mandala, D. Schadendorf, N. Yamazaki, F. Zohren, M. Edwards, P.A. Ascierto
Journal: Annals of Oncology (2021)
640TiP Phase Ib/II trial of pembrolizumab (pembro) + lenvatinib combination therapy in patients (pts) with adenocarcinoma metastatic castration-resistant prostate cancer (mCRPC) or treatment-emergent neuroendocrine mCRPC (t-NE): KEYNOTE-365 cohorts E and F
Authors: G. Kramer, N.D. Shore, A.M. Joshua, X.T. Li, C.H. Poehlein, C. Schloss, J.S. de Bono, E. Yu
Journal: Annals of Oncology (2021)
1350P Characteristics, treatment patterns and outcome of non-small cell lung cancer (NSCLC) patients presenting with brain-only metastatic disease
Authors: A. Sabouhanian, S. Schmid, M. Garcia, L. Zhan, S. Cheng, K. Khan, M.T. Chowdhury, J. Herman, P. Walia, E. Strom, M.C. Brown, D. Patel, W. Xu, F.A. Shepherd, A. Sacher, N. Leighl, P. Bradbury, G. Liu, D. Shultz
Journal: Annals of Oncology (2021)
Association Between K–12 School Mask Policies and School-Associated COVID-19 Outbreaks — Maricopa and Pima Counties, Arizona, July–August 2021
Authors: Megan Jehn, J. Mac McCullough, Ariella P. Dale, Matthew Gue, Brian Eller, Theresa Cullen, Sarah E. Scott
Journal: MMWR Morbidity and Mortality Weekly Report (2021)

CDC recommends universal indoor masking by students, staff members, faculty, and visitors in kindergarten through grade 12 (K-12) schools, regardless of vaccination status, to reduce transmission of SARS-CoV-2, the virus that causes COVID-19 (1). Schools in Maricopa and Pima Counties, which account for >75% of Arizona's population (2), resumed in-person learning for the 2021-22 academic year during late July through early August 2021. In mid-July, county-wide 7-day case rates were 161 and 105 per 100,000 persons in Maricopa and Pima Counties, respectively, and 47.6% of Maricopa County residents and 59.2% of Pima County residents had received at least 1 dose of a COVID-19 vaccine. School districts in both counties implemented variable mask policies at the start of the 2021-22 academic year (Table). The association between school mask policies and school-associated COVID-19 outbreaks in K-12 public noncharter schools open for in-person learning in Maricopa and Pima Counties during July 15-August 31, 2021, was evaluated.
The prognostic role of matrix metalloproteinase-7 in scleroderma-associated interstitial lung disease
Authors: Scott M. Matson, Seoyeon J. Lee, Ryan A. Peterson, Natalia A. Achtar-Zadeh, Francesco Boin, Paul J. Wolters, Joyce S. Lee
Journal: European Respiratory Journal (2021)

Systemic sclerosis (SSc) has the highest mortality rate amongst rheumatologic diseases [1]. It is characterised by endothelial dysfunction resulting in a small vessel vasculopathy leading to inflammation and fibrosis of skin and internal organs, including the lungs [1]. Pulmonary manifestations of SSc (pulmonary hypertension and interstitial lung disease (ILD)) account for the majority of deaths in these patients, and ILD alone accounts for a third of the mortality observed in SSc patients [2]. Matrix metalloproteinase-7 level is associated with worse baseline pulmonary function and worse transplant-free survival in scleroderma interstitial lung disease <https://bit.ly/3zZhja7>
Functioning of the International Health Regulations during the COVID-19 pandemic
Authors: Preben Aavitsland, Ximena Aguilera, Seif Salem Al-Abri, Vincent Amani, Carmen C Aramburu, Thouraya A Attia, Lucille H Blumberg, Malinee Chittaganpitch, James W Le Duc, Dexin Li, Talat Mokhtariazad, Mohamed Moussif, Olubunmi E Ojo, Jean-Marie Okwo-Bele, Tomoya Saito, Amadou Alpha Sall, Mark W A P Salter, Myongsei Sohn, Lothar H Wieler
Journal: The Lancet (2021)
1214P High dose osimertinib in patients with advanced stage EGFR exon 20 mutation-positive NSCLC: Results from a phase II multicenter study, POSITION20
Authors: F. Zwierenga, B.A.M.H. van Veggel, L.E.L. Hendriks, T.J.N. Hiltermann, B.I. Hiddinga, L.B.M. Hijmering-Kappelle, A-M.C. Dingemans, C. van der Leest, A.J. de Langen, M. van den Heuvel, A.J. van der Wekken
Journal: Annals of Oncology (2021)
1616P Drop in early-stage colorectal cancer diagnoses after COVID-19: Preliminary report from the COVID-DELAY study
Authors: G. Mentrasti, V. Cognigni, M. Di Maio, R. Chiari, N. La Verde, C. Zichi, G. Aimar, F. De Vita, S. Marini, M.S. Cona, G. Pinterpe, F. Pecci, A. Migliore, E. Caravita, M.B.L. Rocchi, A. Bittoni, R. Giampieri, L. Cantini, R. Berardi
Journal: Annals of Oncology (2021)
Abnormal liver function tests on admission are associated with increased mortality in hospitalized patients with Covid-19: preliminary results from a large latin american cohort
Authors: Manuel Mendizábal, Ezequiel Ridruejo, Federico Pinero, Margarita Anders, José Scapellato, Álvaro Urzúa Manchego, Aldo Torre, Javier Díaz Ferrer, Adriana Varón, Sandro Ruiz, Daniel Cocozzella, Luis Toro, Esteban González Ballerga, Emilia Vera Pozo, Claudio Toledo Almonacid, Alejandra Domínguez, Mirta Peralta, Damián Conte, Natalia Ratusnu, Matías García, Aldana Scarpin, Julia Brutti, Isabel Gutiérrez Lozano, Miranda Godolfino, Vitoria Mainardi, Martín Tagle, Pedro Montes, María Grazia Venturelli, Carla Bustios, Nataly Escajadillo, Jonathan Aguirre, Josefina Pages, Marcello O. Silva
Journal: Hepatology (2020)